A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma

Carcinogenesis

Volumn 35, Issue 6, 2014, Pages 1362-1370

  Li, Xia ^a   Xu, Qing ^b   Wu, Yuhui ^c   Li, Jinyun ^d   Tang, Dongsheng ^a   Han, Lu ^e   Fan, Qinqiao ^f  

^a FOSHAN UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d HUNAN CANCER HOSPITAL   (China)

^e Foshan Stomatology Hospital   (China)

^f Chenzhou No1 People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CYCLIN D; CYCLIN DEPENDENT KINASE 4; CYCLIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MAMMALIAN TARGET OF RAPAMYCIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; PROTEIN KINASE B; RANTES; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; SUPEROXIDE DISMUTASE; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOREGULATION; CANCER ASSOCIATED FIBROBLAST; CANCER GROWTH; CANCER SIZE; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; CELL MOTION; DISEASE MODEL; FIBROBLAST; GENE EXPRESSION; GENETICS; METABOLISM; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR INVASION; TUMOR VOLUME; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CCL2; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE EXPRESSION; HETEROGRAFTS; HUMANS; MICE; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR BURDEN;

EID: 84898912407     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu046     Document Type: Article

References (44)

1. Neville, B.W. et al. (2002) Oral cancer and precancerous lesions. Cancer J. Clin., 52, 195-215.
2. Parkin, D.M. et al. (2005) Global cancer statistics, 2002. Cancer J. Clin., 55, 74-108.
3. Arduino, P.G. et al. (2008) Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J. Oral Maxillofac. Surg., 66, 1570-1579.
4. Coussens, L.M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
5. Kalluri, R. (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer, 3, 422-433.
6. Kalluri, R. et al. (2006) Fibroblasts in cancer. Nat. Rev. Cancer, 6, 392-401.
7. Olumi, A.F. et al. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res., 59, 5002-5011.
8. Orimo, A. et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 121, 335-348.
9. Sternlicht, M.D. et al. (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell, 98, 137-146.
10. Fujii, N. et al. (2012) Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance. J. Oral Pathol. Med., 41, 444-451.
11. Hayward, S.W. et al. (2001) Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res., 61, 8135-8142.
12. Peña, C. et al. (2013) STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. Cancer Res., 73, 1287-1297.
13. Chang, H.Y. et al. (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl Acad. Sci. USA, 99, 12877-12882.
14. Costea, D.E. et al. (2013) Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma. Cancer Res., 73, 3888-3901.
15. Aprelikova, O. et al. (2010) The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle, 9, 4387-4398.
16. Xu, Q. et al. (2013) A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. J. Mol. Cell Biol., 5, 3-13.
17. Bhowmick, N.A. et al. (2004) Stromal fibroblasts in cancer initiation and progression. Nature, 432, 332-337.
18. Mueller, M.M. et al. (2004) Friends or foes-bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer, 4, 839-849.
19. Kuperwasser, C. et al. (2004) Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl Acad. Sci. USA, 101, 4966-4971.
20. Potula, H.S. et al. (2009) Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration. J. Biol. Chem., 284, 31142-31155.
21. Wolter, S. et al. (2008) c-Jun controls histone modifications, NF-kappaB recruitment, and RNA polymerase II function to activate the ccl2 gene. Mol. Cell. Biol., 28, 4407-4423.
22. Nathan, C. et al. (2013) Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat. Rev. Immunol., 13, 349-361.
23. Martinez-Outschoorn, U.E. et al. (2010) Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle, 9, 3256-3276.
24. Romashkova, J.A. et al. (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature, 401, 86-90.
25. del Peso, L. et al. (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science, 278, 687-689.
26. Cantley, L.C. et al. (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl Acad. Sci. USA, 96, 4240-4245.
27. Bagchi, M. et al. (1998) Naphthalene-induced oxidative stress and DNA damage in cultured macrophage J774A.1 cells. Free Radic. Biol. Med., 25, 137-143.
28. Takeuchi, T. et al. (1996) Relationship between the intracellular reactive oxygen species and the induction of oxidative DNA damage in human neutrophil-like cells. Carcinogenesis, 17, 1543-1548.
29. Ferreira, F.O. et al. (2008) Association of CCL2 with lymph node metastasis and macrophage infiltration in oral cavity and lip squamous cell carcinoma. Tumour Biol., 29, 114-121.
30. Moore, B.B. et al. (2001) Protection from pulmonary fibrosis in the absence of CCR2 signaling. J. Immunol., 167, 4368-4377.
31. Kim, Y. et al. (2001) Enhanced airway Th2 response after allergen challenge in mice deficient in CC chemokine receptor-2 (CCR2). J. Immunol., 166, 5183-5192.
32. Tsuyada, A. et al. (2012) CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells. Cancer Res., 72, 2768-2779.
33. Ueda, A. et al. (1994) NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol., 153, 2052-2063.
34. Pectasides, E. et al. (2010) Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis. Clin. Cancer Res., 16, 2427-2434.
35. Masuda, M. et al. (2002) Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res., 62, 3351-3355.
36. Masuda, M. et al. (2010) Stat3 orchestrates tumor development and progression: the Achilles' heel of head and neck cancers? Curr. Cancer Drug Targets, 10, 117-126.
37. Bancroft, C.C. et al. (2002) Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int. J. Cancer, 99, 538-548.
38. Lin, J. et al. (2010) Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clin. Cancer Res., 16, 77-87.
39. Chung, C.H. et al. (2006) Gene expression profiles identify epithelial-tomesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res., 66, 8210-8218.
40. Lampiasi, N. et al. (2012) The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. Cancer Lett., 322, 35-44.
41. Montero, A.J. et al. (2011) Cellular redox pathways as a therapeutic target in the treatment of cancer. Drugs, 71, 1385-1396.
42. Valent, P. (1995) Cytokines involved in growth and differentiation of human basophils and mast cells. Exp. Dermatol., 4(4 Pt 2), 255-259.
43. Alam, R. et al. (1994) Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J. Immunol., 152, 1298-1303.
44. Loberg, R.D. et al. (2007) CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia, 9, 556-562.